 |
 |

Initial Results From the National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis
Lori R. Armstrong, PhD;
Craig S. Derkay, MD;
William C. Reeves, MD;
and the RRP Task Force
Arch Otolaryngol Head Neck Surg. 1999;125:743-748.
Objective To characterize the spectrum of juvenile-onset recurrent respiratory papillomatosis (RRP) in the United States and to obtain data about the natural course of the disease and its response to treatment.
Setting Twenty tertiary-care pediatric otolaryngology centers throughout the United States.
Patients All patients with active RRP aged less than 18 years at the participating sites.
Main Outcome Measures Number of surgical procedures performed per year, progression of papillomas to previously nondiseased anatomical sites, drug interventions and other adjuvant therapy, and need for tracheostomy.
Results Data were collected from 399 children enrolled from January 1, 1997, through December 31, 1998. There were 51.9% male; 62.7% white, 28.3% black, 9.0% other or unknown racial group; 10.8% Hispanic ethnicity. Mean age at diagnosis was 3.8 years (range, 0.1-16.3 years) and mean duration of disease was 4.4 years (range, 0.03-18.9 years). The mean number of surgical procedures per child was 4.4 per year (range, 0.2-19.3 per year). Children whose RRP was diagnosed at younger ages (<3.0 years) were 3.6 times more likely to have more than 4 surgical procedures per year (P=.001) and almost 2 times more likely to have 2 or more anatomical sites affected (P=.008) than were children whose RRP was diagnosed at later ages (≥3.0 years), after adjusting for sex, race, and years of treatment.
Conclusions Children whose disease was diagnosed before age 3 years were more likely than children aged 3 years or older to have more severe disease as measured by the mean number of surgical procedures performed and by the number of anatomical sites affected. The registry will form the basis for future analysis on the outcome of disease, natural course of RRP under management strategies, prevention strategies, and public health importance.
From the Viral Exanthems and Herpesvirus Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Armstrong and Reeves); and Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk (Dr Derkay). Dr Armstrong is now with the Division of Cancer Prevention and Control, Cancer Surveillance Branch, Centers for Disease Control and Prevention.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
High-Resolution Ultrasound in the Evaluation of Pediatric Recurrent Respiratory Papillomatosis
Bryson et al.
Arch Otolaryngol Head Neck Surg 2009;135:250-253.
ABSTRACT
| FULL TEXT
Efficacy of Treating Children With Anterior Commissure and True Vocal Fold Respiratory Papilloma With the 585-nm Pulsed-Dye Laser
Hartnick et al.
Arch Otolaryngol Head Neck Surg 2007;133:127-130.
ABSTRACT
| FULL TEXT
Recurrent respiratory papillomatosis.
Tasca and Clarke
Arch. Dis. Child. 2006;91:689-691.
ABSTRACT
| FULL TEXT
American Society of Pediatric Otolaryngology Members' Experience With Recurrent Respiratory Papillomatosis and the Use of Adjuvant Therapy
Schraff et al.
Arch Otolaryngol Head Neck Surg 2004;130:1039-1042.
ABSTRACT
| FULL TEXT
Clinical Course of Recurrent Respiratory Papillomatosis in Danish Children
Silverberg et al.
Arch Otolaryngol Head Neck Surg 2004;130:711-716.
ABSTRACT
| FULL TEXT
Predictors of Remission in Juvenile-Onset Recurrent Respiratory Papillomatosis
Ruparelia et al.
Arch Otolaryngol Head Neck Surg 2003;129:1275-1278.
ABSTRACT
| FULL TEXT
HLA-DQ Alleles in White and African American Patients With Juvenile-Onset Recurrent Respiratory Papillomatosis
Gregoire et al.
Arch Otolaryngol Head Neck Surg 2003;129:1221-1224.
ABSTRACT
| FULL TEXT
National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis
Reeves et al.
Arch Otolaryngol Head Neck Surg 2003;129:976-982.
ABSTRACT
| FULL TEXT
Another Potential Adjuvant Therapy for Recurrent Respiratory Papillomatosis
Lieu and Molter
Arch Otolaryngol Head Neck Surg 2002;128:787-788.
FULL TEXT
The Cost of Juvenile-Onset Recurrent Respiratory Papillomatosis
Bishai et al.
Arch Otolaryngol Head Neck Surg 2000;126:935-939.
ABSTRACT
| FULL TEXT
|